Minimally Invasive Esophagectomy Pain Control Trial

Description

A pilot randomized controlled trial comparing intercostal nerve blocks, cryo-ablation plus intercostal nerve blocks, and serratus plane catheter plus intercostal nerve blocks in patients undergoing esophagectomies with minimally invasive thoracic approaches.

Conditions

Postoperative Pain, Acute, Postoperative Complications

Study Overview

Study Details

Study overview

A pilot randomized controlled trial comparing intercostal nerve blocks, cryo-ablation plus intercostal nerve blocks, and serratus plane catheter plus intercostal nerve blocks in patients undergoing esophagectomies with minimally invasive thoracic approaches.

A Randomized Controlled Trial Comparing Local Intercostal Nerve Blocks, Cryo-ablation Plus Intercostal Nerve Blocks, and Serratus Plane Catheter Plus Intercostal Nerve Blocks After Minimally Invasive Esophagectomy

Minimally Invasive Esophagectomy Pain Control Trial

Condition
Postoperative Pain, Acute
Intervention / Treatment

-

Contacts and Locations

Seattle

Swedish Cancer Institute, Seattle, Washington, United States, 98104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 3-hole with R video-assisted thoracoscopic surgery (VATS)
  • * Ivor Lewis R VATS
  • * Age \<18
  • * Unable to consent
  • * Additional surgical procedures planned
  • * Patients with previous thoracic surgery
  • * Patient with chronic pain on a daily regimen of narcotics
  • * Non-English speaking
  • * Contraindications to neuraxial anesthesia (ongoing anticoagulation, anticipated post-operative therapeutic anticoagulation, spinal cord stimulators, anatomic abnormalities preventing epidural placement)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Swedish Medical Center,

Brian Louie, M.D., PRINCIPAL_INVESTIGATOR, Swedish Cancer Institute

Study Record Dates

2026-02